Department of Clinical Epidemiology, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark.
Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Diabetes Obes Metab. 2018 Jun;20(6):1508-1514. doi: 10.1111/dom.13230. Epub 2018 Feb 25.
We conducted a systematic review and meta-analysis of observational studies investigating the association between antibiotic exposure in infancy and risk of childhood overweight and obesity. Thirteen studies, including a total of 527 504 children, were included in the systematic review and 8 were included in meta-analyses. Exposure to antibiotics in infancy was associated with an increased odds ratio (OR) of childhood overweight and obesity (OR 1.11, 95% confidence interval [CI] 1.02-1.20). Whereas exposure to 1 treatment only and exposure between 6 and 24 months were not associated with increased risk of childhood overweight and obesity, exposure to >1 treatment was associated with an OR of 1.24 (95% CI 1.09-1.43) and exposure within the first 6 months of life was associated with an OR of 1.20 (95% CI 1.04-1.37). In conclusion, antibiotic exposure in infancy was associated with a slightly increased risk of childhood overweight and obesity, mainly if children were exposed to repeated treatments or treatment within the first 6 months of life. It is unclear whether this association is mediated via direct effects of antibiotics on the gut microbiota.
我们对研究婴儿期抗生素暴露与儿童超重和肥胖风险之间关联的观察性研究进行了系统回顾和荟萃分析。系统评价纳入了 13 项研究,共涉及 527504 名儿童,meta 分析纳入了 8 项研究。婴儿期抗生素暴露与儿童超重和肥胖的患病风险增加相关(比值比 1.11,95%置信区间 1.02-1.20)。仅接受 1 次治疗或在 6 至 24 个月期间接受治疗与儿童超重和肥胖风险增加无关,而接受 >1 次治疗与患病风险增加相关(比值比 1.24,95%置信区间 1.09-1.43),在生命的前 6 个月内接受治疗与患病风险增加相关(比值比 1.20,95%置信区间 1.04-1.37)。总之,婴儿期抗生素暴露与儿童超重和肥胖风险略有增加相关,主要是如果儿童接受重复治疗或在生命的前 6 个月内接受治疗。目前尚不清楚这种关联是否通过抗生素对肠道微生物群的直接作用来介导。